Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria.
Ito S +8 more
europepmc +1 more source
Two Cases of Crovalimab-Induced Platelet Recovery in Bone Marrow Failure-Associated Paroxysmal Nocturnal Hemoglobinuria (PNH). [PDF]
Onaka T, Yamada Y, Imada K.
europepmc +1 more source
Real-World Evidence of the Disease Burden and Economic Impact of Paroxysmal Nocturnal Hemoglobinuria in Italy. [PDF]
Bini R +5 more
europepmc +1 more source
Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review. [PDF]
Ueda Y +10 more
europepmc +1 more source
Epidemiological estimates of paroxysmal nocturnal hemoglobinuria in Bulgaria. [PDF]
Beleva E.
europepmc +1 more source
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators. [PDF]
Shi JJ +5 more
europepmc +1 more source
Correction to "Successful Haploidentical Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria With Severe Pancytopenia Developed After Long-Term Aplastic Anemia Treatment". [PDF]
europepmc +1 more source
Related searches:
Paroxysmal nocturnal hemoglobinuria
Hématologie, 2013Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder of hematopoietic stem cells. PNH is related to a somatic mutation in the phosphatidylinositol glycan class A (PIG-A), X-linked gene, responsible for a deficiency in glycosylphosphatidylinositol-anchored proteins (GPI-AP).
R, Peffault de Latour +2 more
openaire +2 more sources

